By Carole Tanzer Miller HealthDay ReporterMONDAY, March 23, 2026 (HealthDay News) — Detecting the first signs of Alzheimer’s disease may one day be as easy as swabbing the inside of your nose. An ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way ...

A new type of blood test that analyses the folding of amino acids rather than their amounts may detect earliest biological signs of Alzheimer’s disease ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...

Former KQRS Morning Show host Tom Barnard announced on his podcast that he has been undergoing treatment for Alzheimer's.

At AD/PD 2026, one message stood out: when researchers share ideas across Alzheimer’s and Parkinson’s, it could help speed up progress towards better tests, new treatments and a deeper understanding ...

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...